Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    Open Studies | "Antiretroviral Therapy, Highly Active" OR HAART
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Antiretroviral Therapy, Highly Active" OR HAART
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: HAART;   Drug: Mega-HAART
2 Recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: Human Immunodeficiency Virus
Interventions: Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.
3 Recruiting Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma
Conditions: Lymphoma-AIDS-Related;   Brain Neoplasm
Interventions: Drug: Methotrexate;   Drug: Rituximab;   Drug: Leucovorin
4 Recruiting Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection
Conditions: Acute HIV Infection;   Antiretroviral Treatment Interruption
Intervention: Other: Treatment interruption
5 Recruiting Functional Cure Study of HIV-infected Patients
Condition: HIV
Intervention: Procedure: cART course
6 Recruiting Use of Incentives to Retain Drug Users in HIV Therapy
Condition: HIV Infection
Intervention: Other: monetary reinforcer
7 Recruiting Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)
Conditions: NVP Plasma Level;   NVP Related Mutation;   3TC Related Mutation
Intervention: Drug: AZT/3TC 2 weeks after delivery
8 Recruiting Reconstitution of HIV-specific Immunity Against HIV
Condition: HIV
Intervention: Other: HIV-specific CD8 cells
9 Recruiting Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan
Condition: HIV
Intervention:
10 Recruiting Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Biological: HIVAX;   Biological: saline solution;   Biological: Saline solution
11 Recruiting Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly
Conditions: HIV;   Tuberculosis
Interventions: Drug: Lopinavir/r will be supplied by NHSO/GPO;   Drug: Rifabutin
12 Recruiting Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
Conditions: AIDS-Related Hodgkin Lymphoma;   AIDS-Related Non-Hodgkin Lymphoma;   HIV Infection;   Recurrent Hodgkin Lymphoma;   Recurrent Non-Hodgkin Lymphoma
Interventions: Biological: Gene-Modified HIV-Protected Hematopoietic Stem Cells;   Other: Laboratory Biomarker Analysis;   Other: Transplant Conditioning
13 Recruiting Body Image and Self-Care in HIV-Infected MSM
Conditions: Body Image Disturbance;   Medication Adherence
Interventions: Behavioral: Experimental Intervention;   Behavioral: TAU
14 Recruiting The Use of Leukapheresis to Support HIV Pathogenesis Studies
Condition: HIV
Intervention: Procedure: Leukapheresis
15 Recruiting Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy
Condition: HIV-1 Infection
Intervention: Biological: HIV DNA
16 Recruiting Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial
Condition: HIV
Interventions: Drug: Nevirapine (NVP);   Drug: Zidovudine (ZDV);   Drug: Lamivudine (3TC)
17 Recruiting A Prospective Cohort of Children With HIV Infection
Condition: HIV Infections
Interventions: Drug: Zidovudine, Stavudine, Didanosine, Lamivudine;   Drug: Nevirapine, Efavirenz;   Drug: LPV/r, Saquinavir, Indinavir, Ritonavir, Nelfinavir
18 Recruiting AIDS 347: IL-6 Blockade in Treated HIV Infection
Condition: HIV Infections
Interventions: Drug: tocilizumab;   Drug: Placebo
19 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy

Study has passed its completion date and status has not been verified in more than two years.